Intracerebral Hemorrhage Clinical Trials in St Louis, Missouri

4 studies are recruiting for intracerebral hemorrhage in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. CoMind Early Feasibility Study

    The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pres…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Washington University Medical Center, St Louis, Missouri
    Locations
    16 in total
    Run by
    CoMind Technologies Limited

    See if you can join NCT06368648 on ClinicalTrials.gov

  2. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

    The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is tha…

    Stage
    Phase 3
    Ages
    18 to 80
    Site
    Barnes Jewish Hospital, St Louis, Missouri
    Locations
    89 in total
    Run by
    Joseph Broderick, MD

    See if you can join NCT07227246 on ClinicalTrials.gov

  3. Auricular VNS Following Intracerebral Hemorrhage

    This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Washington University School of Medicine, St Louis, Missouri
    Run by
    Washington University School of Medicine

    See if you can join NCT06799390 on ClinicalTrials.gov

  4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Barnes Jewish Hospital, St Louis, Missouri
    Locations
    187 in total
    Run by
    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.